Journey Medical Corp financial data

Symbol
DERM on Nasdaq
Industry
Pharmaceutical Preparations
Location
9237 E Via De Ventura Blvd., Suite 105, Scottsdale, AZ
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 132 % +49.3%
Quick Ratio 28.5 % +46.6%
Debt-to-equity 391 % -44.5%
Return On Equity -132 % -11.9%
Return On Assets -26.9 % -83.3%
Operating Margin -31.2 % -150%

Shares

Label TTM Value / Value Unit Change %
Common Stock, Shares, Outstanding 11.6M shares
Entity Public Float 12.3M USD -53.7%
Weighted Average Number of Shares Outstanding, Basic 20.5M shares +11.5%
Weighted Average Number of Shares Outstanding, Diluted 20.5M shares -2.36%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 57.8M USD -27.7%
Revenue from Contract with Customer, Excluding Assessed Tax 57.8M USD -4.24%
Cost of Revenue 24.7M USD -13.1%
Research and Development Expense 11.1M USD +8.28%
Costs and Expenses 75.8M USD -15.7%
Operating Income (Loss) -18M USD -80.8%
Nonoperating Income (Expense) -195K USD +91.4%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -18.2M USD -48.7%
Income Tax Expense (Benefit) 95K USD +850%
Net Income (Loss) Attributable to Parent -18.3M USD -48.4%
Earnings Per Share, Basic -0.91 USD/shares -24.7%
Earnings Per Share, Diluted -0.8 USD/shares +4.76%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 22.5M USD -9.25%
Accounts Receivable, after Allowance for Credit Loss, Current 10.7M USD +33.6%
Inventory, Net 11.8M USD +6.93%
Assets, Current 46.2M USD +3.3%
Operating Lease, Right-of-Use Asset 32K USD -74.2%
Intangible Assets, Net (Excluding Goodwill) 17.8M USD -15.4%
Other Assets, Noncurrent 6K USD 0%
Assets 64M USD -2.84%
Accounts Payable, Current 15.3M USD -45.5%
Accrued Liabilities, Current 16M USD -0.11%
Liabilities, Current 33.3M USD -31.3%
Operating Lease, Liability, Noncurrent 9K USD -91.7%
Liabilities 53.1M USD +9.42%
Retained Earnings (Accumulated Deficit) -88.5M USD -26.1%
Stockholders' Equity Attributable to Parent 10.9M USD -37.1%
Liabilities and Equity 64M USD -2.84%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -5.02M USD -425%
Net Cash Provided by (Used in) Financing Activities 1.64M USD +3048%
Net Cash Provided by (Used in) Investing Activities -5M USD +75%
Common Stock, Shares Authorized 50M shares 0%
Common Stock, Shares, Issued 11.6M shares
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -3.38M USD +42.7%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 22.5M USD -9.25%
Interest Paid, Excluding Capitalized Interest, Operating Activities 267K USD -50.1%
Deferred Tax Assets, Valuation Allowance 20.2M USD +4.39%
Deferred Tax Assets, Gross 20.2M USD -0.87%
Operating Lease, Liability 34K USD -74%
Lessee, Operating Lease, Liability, to be Paid 34K USD -76.4%
Operating Lease, Liability, Current 34K USD -64.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 9K USD -91.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 9K USD -91.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1K USD -85.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 9K USD
Deferred Tax Assets, Operating Loss Carryforwards 4.38M USD -33.2%
Unrecognized Tax Benefits 0 USD
Operating Lease, Payments 106K USD +19%
Additional Paid in Capital 99.5M USD +13.6%
Amortization of Intangible Assets 814K USD -23.9%
Deferred Tax Assets, Net of Valuation Allowance 25K USD -97.6%
Share-based Payment Arrangement, Expense 5.25M USD +49.2%
Interest Expense 1.6M USD -30%